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Identifying genomic variation is a crucial step for unraveling the relationship between genotype and phenotype and can yield important
insights into human diseases. Prevailing methods rely on cost-intensive whole-genome sequencing (WGS) or whole-exome sequencing
(WES) approaches while the identification of genomic variants from often existing RNA sequencing (RNA-seq) data remains a challenge
because of the intrinsic complexity in the transcriptome. Here, we present a highly accurate approach termed SNPiR to identify SNPs in
RNA-seq data. We applied SNPiR to RNA-seq data of samples for which WGS and WES data are also available and achieved high spec-
ificity and sensitivity. Of the SNPs called from the RNA-seq data, >98% were also identified by WGS or WES. Over 70% of all expressed
coding variants were identified from RNA-seq, and comparable numbers of exonic variants were identified in RNA-seq andWES. Despite
our method’s limitation in detecting variants in expressed regions only, our results demonstrate that SNPiR outperforms current state-of-
the-art approaches for variant detection from RNA-seq data and offers a cost-effective and reliable alternative for SNP discovery.Introduction
Our ability to decipher the relationship between genotype
and phenotype relies on the effective identification of
genomic variation. The advent of next-generation
sequencing has greatly facilitated this endeavor. Whole-
genome sequencing (WGS) or whole-exome sequencing
(WES) has been a common practice in many large-scale
projects, such as the 1000 Genomes and The Cancer
Genome Atlas projects, in which its main uses comprise
the identification of genomic variants,1–3 many of which
improve our understanding of human diseases.4–6 RNA
sequencing (RNA-seq) is arguably a more popular applica-
tion because it costs less than genome sequencing and
has the ability to address a multitude of different ques-
tions, such as the quantification of gene expression levels,
detection of alternative splicing, allele-specific expression,
gene fusions,7–10 or RNA editing.11–13
Employing RNA-seq data for identifying genomic vari-
ants, however, remains a challenge because of the tran-
scriptome’s intrinsic complexity (e.g., splicing), which
leads to the technical difficulty of the computational anal-
ysis. What are the benefits of calling variants from RNA-seq
data? First, a large number of samples with available RNA-
seq data do not come with matched WGS or WES data.
Calling variants in them is ‘‘free,’’ an additional deliverable
of the existing RNA-seq data. Second, a large number of
disease samples might have both RNA-seq and WGS or
WES data. Calling SNPs from the WGS or WES data can
be challenging because of the heterogeneity of the disease
samples (e.g., tumors). De novo variant calling in RNA-seq
data provides an efficient option to validate the findings
from the WGS or WES data.
Recent developments in computational approaches to
identifying SNPs in cancer14 and accurate mapping of
RNA-seq reads15 have resulted in the identification of1Department of Genetics, Stanford University, Stanford, CA 94305, USA
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The Americpotentially disease-associated variations in RNA-seq
data.16–18 These studies either imposed strong variant
filtering criteria and thus limited their analysis to several
candidate sites16 or required data from multiple individ-
uals and the aid of additional WES for the accurate identi-
fication of variants.19 This handful of studies also demon-
strates the utility of detecting genetic variants and somatic
mutations with the use of RNA-seq data, underscores the
considerable effort underlying these investigations, and
highlights the need for automated, high-accuracy determi-
nation of RNA variants. Correct mapping of RNA-seq reads
to the reference genome is crucial for avoiding mismatches
that are incorrectly interpreted as SNPs. The assignment of
reads to their original genomic location is mostly
hampered by (1) highly similar regions in the genome,20
(2) artifacts in library construction,21 and (3) the inability
of many computational pipelines to map reads in a
splice-aware manner (this last hindrance is possibly the
greatest challenge to the accurate detection of SNPs). The
vast majority (>90%) of the transcripts in the human
genome are spliced version of genes.22 In addition, recent
studies have revealed that alternative splicing occurs in
over 90% of genes.23 Given the average length of human
exons (~150 bp) and the read lengths of current
sequencing technologies (two paired-end 100 bp reads),
sequencing of these transcripts often results in sequencing
reads that span splice junctions. Current methods24–26
might achieve satisfactory mapping performance for
RNA-seq expression studies and the identification of alter-
native splicing. For the purpose of variant calling fromRNA-
seq data, however, they still suffer from an unacceptably
high rate of wrongly mapped reads. In addition, they fail to
account forotherRNA-seq-study specifics that couldhamper
the accurate identification of genomic variants. Recently,
several methods for the discovery of RNA-editing sites from
transcriptomedatahavebeendescribed.11–13,27–29Althoughy of Human Genetics. All rights reserved.
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many of them take some of the above concerns into consid-
eration, there exists no account that describes a fully
integrated approach for the detection of single-nucleotide
variants from RNA-seq experiments.
Here, we present a simple yet highly accurate method
termed SNPiR to identify SNPs in RNA-seq data. SNPiR con-
sists of (1) a modified RNA-seq read-mapping procedure
that allows alignment of reads to the reference in a
splice-aware manner, (2) variant calling using the Genome
Analysis Toolkit (GATK),30 and (3) vigorous filtering of
false-positive calls. The steps in our computational pipe-
line are inspired by common practice for mapping, variant
calling, and variant filtering inWGS andWES experiments
but were modified to account for the specific characteris-
tics of RNA-seq experiments, including errors introduced
during RNA-seq library preparation, sequencing, and
read-mapping difficulties due to highly similar genomic
regions. The application of our method to two well-charac-
terized samples allows a systematic assessment of sensi-
tivity and specificity and highlights the immense impor-
tance of variant filtering for avoiding false-positive calls.Figure 1. A Computational Framework for the Identification of
SNPs from Transcriptome Data
Shown are RNA-seq readsmapped to the human reference genome
(blue lines) and all regions spanning known splice junctions (yel-
low lines separated by dashes). Subsequent variant calling used
GATK and filtering to remove spurious sites, generating a high-
confidence set of SNVs.Material and Methods
SNPiR: A Pipeline for the Detection of SNPs
in RNA-Seq Data
We have developed a highly efficient procedure (SNPiR) to reli-
ably identify SNPs in RNA-seq data (Figure 1). First, RNA-seq
reads are mapped to the reference genome and all known splice
junctions. The presence of sequences that surround splice junc-
tions allows the short read mapper to correctly assign spliced
reads to their genomic location given that its originating junc-
tion is present in the reference. Uniquely mapped reads are
then used for calling the initial set of candidate variants with
the use of GATK,30 which takes the number of original and alter-
native alleles and their quality into account for variant calling.
Subsequently, these candidates are subjected to several filtering
criteria for ensuring the removal of technical artifacts that might
have been introduced during RNA-seq library preparation,
sequencing, or computational analysis.21 These filters include
removal of false calls in duplicated regions, in homopolymeric re-
gions, or close to splice junctions. The resulting set of RNA-seq
variants is further compared to the catalog of known RNA-editing
sites12,13 for the separation of genomic SNPs from RNA-editing
sites.
RNA-Seq Mapping
We obtained poly(A)þ RNA-seq data for (1) whole GM12878 lym-
phoblastoid cells from the ENCODE project (Gene Expression
Omnibus [GEO] accession number GSM758559) and (2) periph-
eral-blood mononuclear cells (PBMCs) from one healthy individ-
ual31 (GEO GSE33029). The strand-specific RNA-seq libraries
were made as described previously.32 Both samples were deeply
sequenced on the Illumina HiSeq platform. For GM12878 cells,
the transcriptome was sequenced in two biological replicates, re-
sulting in 235.8 and 263.7 million paired-end 76 bp sequencing
reads, respectively (Table S1, available online). The PBMC data
were obtained from samples of a 20-point time series, which re-
sulted in a total of 3,232 million paired-end 101 bp reads. We642 The American Journal of Human Genetics 93, 641–651, Octoberchose the Burrows-Wheeler Aligner (BWA)33 as the mapper for
RNA-seq reads because of its demonstrated high accuracy of align-
ment34 (although untested in our study, other gapped aligners
with high mapping specificity35,36 might give similar results).
We mapped each of the paired-end reads separately by using the
commands ‘‘bwa aln fastqfile’’ and ‘‘bwa samse -n4.’’ In contrast
to previous approaches, we mapped RNA-seq reads not only to
the reference genome11,29 or the transcriptome27,37 but to a
combination of the hg19 reference genome (UCSC Genome
Browser) plus exonic sequences surrounding all currently known
splice junctions from gene models available in annotations from
GENCODE, RefSeq, Ensembl, and the UCSC Genome Browser.
These short pseudochromosomes allowed us to capture reads
derived from transcript regions that span splice junctions and to
assign them to the correct genomic location. We chose the length
of these splice-junction regions to be slightly shorter than the
RNA-seq reads to avoid simultaneous hits to the reference genome
and the splice junctions (for 76 bp reads, a 75 bp region upstream
and downstream was chosen; for 101 bp reads, a 95 bp region up-
stream and downstream was chosen). When the adjacent exons
upstream and/or downstream of a splice junction were shorter
than the required length, we extended the regions across multiple
exons. Although this strategy can avoid the mismapping of most
split reads, some others might still be wrongly placed onto the
genome or split incorrectly. SNPiR avoids such potential false-pos-
itive variant calls through an additional BLAT step, as described in
the next paragraph. We only considered uniquely mapped reads
with mapping quality q > 10 and used SAMtools rmdup38 to3, 2013
remove identical reads (PCR duplicates) that mapped to the same
location. Of these identical reads, only the read with the highest
mapping quality was retained for further analysis.RNA-Seq Variant Calling and Filtering
Mapped reads were subject to local realignment, base-score recali-
bration, and candidate-variant calling with the IndelRealigner,
TableRecalibration, and UnifiedGenotyper tools from GATK.30 In
contrast to common-practice variant calling, we called variants
with very loose criteria by using the UnifiedGenotyper tool with
options stand_call_conf of 0 and stand_emit_conf of 0 and output
mode EMIT_ALL_CONFIDENT_SITES, which allowed a high sensi-
tivity of SNPiR. This set of candidate variants was subject to several
filtering steps that increased the precision of SNPiR (Figure S1).
More specifically, we required a variant call quality Q > 20, dis-
carded variants if they occurred in the first six bases of a read,
and removed variants in repetitive regions according to Repeat-
Masker annotation provided through the UCSC Genome Browser.
Furthermore, we removed intronic variants if they were within
4 bp of splice junctions and filtered variants in homopolymer
runs R 5 bp. Both of these filter settings proved effective in the
removal of false-positive variant calls in previous sequence ana-
lyses.12,13 Moreover, we ensured that reads supporting a variant
were uniquely mapped to the genome. For that purpose, we
used BLAT39 to remap all reads supporting a variant to the
genome. For each read, we required that (1) the best hit overlap
with the variant site and (2) the second best hit have a score <
95% of the best hit. We only retained variant sites if the majority
of supporting reads fulfilled these criteria. Finally, we removed all
currently known RNA-editing sites that were found by recent
high-throughput studies.12,13 (This final step can be omitted if
the user chooses to identify not only genomic variants but also
RNA-editing sites.) We used ANNOVAR40 to annotate variants on
the basis of gene models from GENCODE, RefSeq, Ensembl, and
the UCSC Genome Browser. We defined all RNA-seq variants
that can also be identified fromWGS data or are present in dbSNP
(version 135) as ‘‘known’’ variants. Conversely, all RNA-seq
variants that cannot be found in WGS or in dbSNP were denoted
as ‘‘novel.’’ The precision of SNPiR was calculated as the number of
all known RNA-seq variants divided by the total number of known
and novel RNA-seq variants. To allow a fair comparison between
RNA-seq and WGS variants, we determined the sensitivity of
SNPiR as the fraction of coding exonic variants identified from
WGS.WGS and WES Mapping and Variant Calling
WGS and WES data for the GM12878 cell line were provided in
mapped form by the 1000 Genomes Project (see Web Resources).
The genomewas sequenced at 443 coverage.1WGS andWES reads
for the PBMCs were available from the Sequence Read Archive
under accessions SRP008054.4 and SRA040093, respectively. We
mapped the PBMC data by using the BWA in paired-end mode
with commands ‘‘bwa aln fastqfile1,’’ ‘‘bwa aln fastqfile2,’’ and
‘‘bwa sampe.’’ Realignment, recalibration, and variant calling
were performed with GATK. For variant calling and filtering in
WGS and WES data, we applied the same parameter set as done
by the 1000 Genomes Project Consortium. More precisely, we
used the UnifiedGenotyper with options stand_call_conf of 30
and stand_emit_conf of 10 and filtering criteria as described by
the 1000 Genomes Project Consortium.1 We chose to use these
widely accepted guidelines for variant calling to obtain a high-The Americconfidence variant set that could be used as the gold standard in
our analysis.
Expression Analysis
The expression of known genes (i.e., expected fragments per kilo-
base of transcript per million fragments mapped [FPKM]) was
quantified with cufflinks41 (parameter -G) on the basis of
Tophat242 mappings. Gene models were obtained from the
UCSCGenome Browser for reference genes. If a variant overlapped
with several gene models, the average FPKM for all overlapping
genes was calculated.Results
High Precision of SNP Detection in RNA-Seq Data
We applied SNPiR to data from the GM12878 human lym-
phoblastoid cell line1 and PBMCs from another healthy
individual31 (Table S1). These resources have three major
advantages. First, the transcriptome, exome, and whole
genome of these samples have been deeply sequenced
and allow accurate identification of variants from RNA
and DNA of the same individual. Second, the matched
RNA andDNA samples enable verification of RNA SNP calls
because they can be compared to variation present in the
DNA. Third, the GM12878 cell line has been extensively
studied, and SNPs detected in its genome have been
continuously deposited into dbSNP, making it a good
candidate set for evaluating the precision and sensitivity
of SNPiR.
Using the approach described in Figure 1, we identified
SNPs in the transcriptomes of GM12878 cells and PBMCs.
At the same time, we used common-practice variant calling
as performed by the 1000 Genomes Project1 to catalog var-
iants in the WGS andWES data of the same samples. In to-
tal, we were able to detect 172,982 variants in the
GM12878 RNA-seq data and 299,153 variants in the
PBMC RNA-seq data (Table S1). The larger number of
PBMC variants can be attributed to the larger size of the
RNA-seq data set and thus higher coverage and confidence
in variant calls. We found that SNPiR detected genomic
SNPs with high precision, given that 99.1% of the
GM12878 variants and 96.6% of the PBMC variants that
were discovered from RNA-seq were also called through
WGS data (Figure 2) and that 99.6% (172,322) of the
GM12878 variants and 97.7% (292,224) of the PBMC var-
iants were supported by evidence from WGS or dbSNP
v.135 (Figures S2A, S2C, S2D, and S2F). For both
GM12878 cells and PBMCs, these known sites exhibited
a transition-to-transversion (ts/tv) ratio of 2.25, which is
similar to the overall ts/tv ratio of 2.0–2.1 for the entire
human genome1,43–45 and estimates of ~3 for exonic re-
gions46 and thus is a good reflection of the genomic varia-
tion in transcribed regions.1 Also, the mutational profile of
known variants matched well with the expectations for
genomic regions given that similar profiles of variants
were observed in WGS data (Figure S3). For the remaining
(novel) sites (600 in GM12878 data and 6,929 in PBMCan Journal of Human Genetics 93, 641–651, October 3, 2013 643
Figure 2. Comparison of SNPs Identified via RNA-Seq and WGS
of GM12878 Cells and PBMCs
SNPiR achieved high precision for both GM12878 (A) and PBMC
(B) data sets, given that most of the RNA-seq variants were also
identified by WGS of the same subject. Numbers in parentheses
give the percentage of RNA-seq variants found in WGS.
Figure 3. Characteristics of SNPs Identified from RNA-Seq Data
of GM12878 Cells
(A) The composition of genomic regions for variants in WGS,
WES, and RNA-seq suggests a high enrichment of RNA-seq vari-
ants in functionally important regions. Sites present in RNA-seq
and WES occurred substantially more often in coding exons.
(B) Overlap in coding variants detected from RNA-seq and WGS.
Of all coding variants, 40.2% were found by RNA-seq. The major-
ity of the remaining sites were not detected as a result of the lack of
expression. ‘‘No variation’’ indicates that the position was homo-
zygous in RNA, ‘‘OK but filtered’’ indicates that the position was
heterozygous but was removed by one of our filtering steps, and
‘‘not expressed’’ indicates that the position was not covered by
RNA-seq reads.data), we observed higher ts/tv ratios than for the known
sites (2.49 in GM12878 data and 3.58 in PBMC data). We
found that ~27% of our novel variants in GM12878 data
and ~7% in PBMC data were supported by variant reads
in WGS data (Figure S4A). The remaining novel sites
showed a clear enrichment of A>G and T>C variation
(70.1% for GM12878 data and 71.1% for PBMC data),
indicative of the dominant A-to-I RNA editing47
(Figure S4B). The fraction of A>G and T>C variants was
even higher (92.1%) for the 64 novel sites shared between
the two data sets. Given the fact that the genomes of these
two individuals were deeply sequenced, most of the
genomic SNPs had already been identified. It was therefore
expected that novel SNPs identified in the RNA-seq data
would be enriched with RNA-editing sites. Although our
computational pipeline includes the removal of all
currently known RNA-editing variants identified from
high-throughput studies12,13 (1,369,030 sites in total),
this catalog is still far from being complete, and thus
some variants in our analysismight have remained uniden-
tified as RNA editing. However, our results show that RNA-
editing events are rare compared to the number of SNPs
that can be found in a human genome.Moreover, the rapid
growth of the RNA-editing catalog in humans will allow us
to filter known RNA-editing sites and thus increase the pre-
cision of SNPiR to find genomic variants only.
Enrichment of Variants in Functional Categories
For expressed genes, the use of RNA-seq data for SNP call-
ing can be advantageous compared to WGS because it en-644 The American Journal of Human Genetics 93, 641–651, Octoberriches for expressed genic regions and thus increases the
power to detect functionally important SNPs. Using RNA-
seq data rather than WGS or WES allowed us to enrich
for variants in coding exons, UTRs, and introns
(Figure 3A). The SNPs discovered by SNPiR were highly
abundant in these three categories. Only a small fraction
fell into intergenic regions. The large number of intronic
variants in our analysis can be explained by the facts that
(1) poly(A)þ RNA-capturing protocols can also capture a
small fraction of pre-mRNAs (that still contain introns),
(2) introns compose a much larger fraction of the human
genome than do exonic regions, and (3) much more varia-
tion exists in introns than in exonic regions because of the
higher selective pressures on the exonic portion of the
genome to correctly encode proteins. Given the very
high sequencing coverage of the GM12878 sample,
many intronic regions were covered with low sequencing3, 2013
Figure 4. High Sensitivity of SNPiR Variant Calling in Coding
Regions of Expressed Genes of GM12878 Cells
(A) Sensitivity and number of detected variants called from RNA-
seq data in dependence of the minimum gene expression (in
FPKM).
(B) Cumulative distribution of expression levels (in FPKM) for all
reference genes.depth. The high sensitivity of our method allowed us to
detect many intronic variants from these regions of low
sequence coverage. Although exome-capturing techniques
are commonly used to enrich genic regions, we have found
that WES variant calls for GM12878 and PBMC data only
overlap with variants discovered in the transcriptome to
a surprisingly small extent (Figures S2B and S2E). This sit-
uation occurs because exome-capturing kits are mostly de-
signed to capture the protein-coding portion of the
genome, whereas transcriptome sequencing also provides
information about UTRs and intronic regions. Neverthe-
less, the agreement between RNA-seq and WES is substan-
tially higher in coding regions than in any other category
(in Figure 3A, the fraction of coding sites is markedly
higher in the overlap between RNA-seq and WES than in
the single techniques). When focusing on coding sites
only, we found that 33.4% of SNPs identified by WES in
GM12878 cells were also identified by SNPiR using the
RNA-seq data. As a result of no or very low coverage,
81.5% of the remaining 66.6% of SNPs were not identified.
We have demonstrated that our method can achieve high-
ly confident variant calls. For that reason, the small overlap
between WES and RNA-seq variants suggests that RNA-seq
has the power to uncover variants that are in UTRs and in-
trons and that might have important regulatory functions
but are missed in WES screens. Therefore, our results sug-
gest that transcriptome variant discovery could serve as a
complementary approach to WES for the detection of
nucleotide variation.The AmericHigh Sensitivity in Coding Regions
To calculate the sensitivity of SNPiR, we focused on vari-
ants in coding regions only. The comparison of all RNA
variants to all whole-genome variants would not have
been fair because of the limited representation of the
human genome by RNA transcripts (Figure 3A). Neverthe-
less, we found that RNA-seq data alone enabled the discov-
ery of 40.2% and 47.7% of all coding variants identified by
WGS in GM12878 cells and PBMCs, respectively. At the
same time, RNA-seq only required a fraction of the
sequencing effort (e.g., 499 million [for RNA-seq] versus
2,976 million [for WGS] sequencing reads for GM12878
data). Naturally, SNPiR is restricted to the detection of var-
iants in genic regions, specifically in genes that are being
expressed in the cell under the sampling conditions.
Therefore, the SNPs that had known function in coding
exons but that were not detected by analysis of the tran-
scriptome were mainly missed because of the lack of tran-
scription of these genes (Figure 3B). When we compared
the RNA-seq variants only to WGS variants in expressed
genes (characterized by FPKM > 0.2), the sensitivity of
SNPiR increased from 40%–50% to >70% (Figure 4A).
This agrees with the fact that a large fraction of genes are
expressed at very low levels (Figure 4B). Therefore, our
initial results show that SNPiR achieves high sensitivity
and precision for variant calling in expressed genes.
Precision and Sensitivity for Low-Depth RNA-Seq Data
Many of the currently available RNA-seq data sets vary in
read lengths and read numbers. Our results are based on
very deeply sequenced RNA-seq libraries (499million reads
for GM12878 data and 3,232million reads for PBMC data).
However, in many other experimental settings, the
sequencing depth is often lower. To test the performance
of SNPiR for smaller RNA-seq data sets, we carried out three
random samplings of 5, 10, 20, 50, and 100 million reads
from the GM12878 RNA-seq data set. Our results were
highly reproducible for all sample sizes (Table S2). In gen-
eral, fewer sites were detected for smaller subsets
(Figure 5A). Nevertheless, we detected more than half of
the coding variants of the complete data set (499 million
reads) by using a subsample of only 20 million reads
(Figure 5B). In addition, we found an enrichment of coding
variants for smaller sample sizes (Figure 5C) as a result of
the overall higher coverage of coding regions with RNA-
seq reads (higher coverage allows reliable variant calls
despite the lower total read number). The precision of
SNPiR remained very high (0.980 - 0.997) for all sampling
sizes, given that nearly all detected variants are known
(Figure 5A), and the mutational profile was similar to
that generated from WGS data (Figure 5D).
Comparison of Sensitivity and Precision between
RNA-Seq and WES Experiments
To evaluate the performance of SNPiR, we compared its
sensitivity and precision to those of WES in (1) regions
that are annotated as protein coding in the Consensusan Journal of Human Genetics 93, 641–651, October 3, 2013 645
Figure 5. Subsampling of RNA-Seq Reads
Subsamplings of 5, 10, 20, 50, and 100 million reads were generated from the total set of 499 million GM12878 RNA-seq reads. We
compared (A) the number of discovered variants, (B) the number of variants in coding regions, and (C) the genomic location of variants
between the random samplings and the complete set RNA-seq reads, as well as (D) themutational profile of known RNA-seq variants and
genomic variants. In (A) and (B), ‘‘known’’ variants denote all variant sites that were discovered from RNA-seq and were either confirmed
through WGS or present in dbSNP. Conversely, ‘‘novel’’ denotes all variants that were previously not found from WGS or dbSNP. The
total amounts of novel variants per sample size are shown as small numbers above the data series.Coding Sequence (CCDS) database and are commonly tar-
geted in WES and (2) exonic regions (coding exons and
UTRs). For that purpose, we used the PBMC WES library
of 94.1 million mapped reads and matched its size by sub-
sampling the same number of reads from the larger PBMC
RNA-seq data. Sensitivity was calculated as the number of
correctly identified variants divided by the total number
of variants identified from high-coverage WGS in the
same regions. Precision was calculated as the number of
correct variant calls divided by the number of correct and
false variant calls.
In the CCDS regions, we identified 22,052 variants
through WGS and were able to recover 17,922 (81.3%)
and 9,892 (44.9%) of them through WES and RNA-seq,
respectively (Figure 6A). The majority of the variants
discovered by SNPiR overlapped with sites found in WES.
Although the number of variants discovered by SNPiR
decreased with coverage (Figures S5A and S5B), its sensi-
tivity increased rapidly with larger numbers of covering
reads (Figure S5C). SNPiR’s precision was remarkably
high for all coverage levels and could compete with that
of WES (Figure S5D). The smaller total number of variants
detected by SNPiR compared to WES can be explained by
the lower coverage of the CCDS regions by RNA-seq reads
and the nature of our method to scale with the number of
mapped reads. Only 35.1 million (37.3%) of the sampled
94.1 million RNA-seq reads covered CCDS annotations,
whereas 60.2 million (64%) of the WES reads were located
in the same regions and thus led to a larger number of de-646 The American Journal of Human Genetics 93, 641–651, Octobertected variants in WES. The remaining 62.7% of RNA-seq
reads that did not cover CCDS regions enabled us to
discover variation in genomic regions not commonly
covered by WES. When we targeted all 62,028 genomic
variants in exonic regions (coding and UTR exons), the
numbers of variants discovered through WES and RNA-
seq were very close to each other: we were able to recover
23,693 (38.2%) WGS variants by using WES and 24,987
(40.3%) variants by using RNA-seq (Figure 6B and Figures
S5A and S5B). This highlights the utility of SNPiR for the
detection of genomic variants that have potential regulato-
ry function but that are commonly not targeted by WES
and emphasizes its importance as a complementary
approach to variant discovery from WES.
SNPiR Achieves Higher Precision and Sensitivity than
RNASEQR
To further evaluate the performance of SNPiR, we
compared it to RNASEQR, which is the current most accu-
rate method for RNA-seq mapping given that compared to
other RNA-seq mappers, it yields the smallest number of
false-positive RNA-seq variant calls.15 RNASEQR uses a
three-step approach in which it maps (1) reads to the tran-
scriptome, (2) unmapped reads to the reference genome in
order to detect novel exons, and (3) unmapped reads in a
split fashion to the reference genome and transcriptome
to discover novel splice junctions. In contrast to SNPiR,
which uses the BWA33 as a mapping algorithm, RNASEQR
employs Bowtie (v.0.12.7),48 which we previously3, 2013
Figure 6. Comparison of Genomic Variants Identified in CCDS
and Exonic Regions by WGS, WES, or RNA-Seq
An equal number of reads (94.1 million) of RNA-seq andWES data
was used for fair comparison of variants identified in CCDS re-
gions (A) and exonic regions (B).R
Figure 7. Comparison of SNPiR with RNASEQR
Overlap between the sites detected by SNPiR and RNASEQR on the
same RNA-seq data set for GM12878 cells (A) and the number of
known and novel variants discovered by SNPiR and RNASEQR,
the precision and sensitivity of variant calling, and the ts/tv ratio
for each category (B). Precision was calculated as the fraction of
RNA-seq variants either supported by WGS or present in dbSNP.
Sensitivity was determined as the fraction of WGS variants both
found in coding regions and discovered in the RNA-seq data.demonstrated to have inferior performance for the detec-
tion of transcriptomic variants because it does not support
gapped alignment.21 We applied RNASEQR to the same
GM12878 and PBMC data that were used in our pipeline.
We called variants by using the same parameters as previ-
ously done with RNASEQR to identify SNPs in RNA-seq
data15 (Table S3). SNPiR detected a slightly smaller number
of variants (172,982 sites) in the GM12878 sample than
did RNASEQR (200,318 sites) (Figure 7A), mainly because
of an unexpected, large number of novel variants
(18,840) identified by RNASEQR (SNPiR only identified
660) (Figure 7B). The ts/tv ratio for known variants identi-
fied by SNPiR appeared to be in the normal range, whereas
novel variants showed the expected excess of A>G and
T>C (see above). On the other hand, the low ts/tv ratio
(1.23) for the novel SNPs identified by RNASEQR suggests
a higher false-positive rate (Figure 7B and Figure S6A). In
fact, a larger portion of the novel RNASEQR variants in
the GM12878 sample did not show any support in WGS
(compare Figures S4A and S6B) and did not show any
enrichment of A>G and T>C types (compare Figures S4B
and S6C).
We examined the 18,840 novel sites identified by RNA-
SEQR and found that the majority of them (>13,000)
were false calls. First, we found that despite the efforts by
RNASEQR to report uniquely mapped reads, 10,531 sites
(55.9%) were supported by nonunique mappings only
and were removed by the BLAT filter in SNPiR. Reads
that support such variants have the same or even higher
BLAT mapping scores in other genomic locations at which
the alternative nucleotide matches the reference genome
(Figure S7A). If mapped incorrectly, such reads result in
mismatches from the reference genome, which in turn
are wrongly identified as single-nucleotide variants. Sec-
ond, our BLAT filter was also able to identify 1,273 false
variants close to exon-intron junctions in the RNASEQR
mappings. By correctly mapping spliced reads across junc-
tions, it prevented them from extending into intronic re-
gions, where they could have caused mismatches
(Figure S7B). Third, variation at 50 read ends, most of which
was shown to be due to technical artifacts,21,49,50 ac-The Americcounted for 1,629 sites. Fourth, we found 53 sites located
in homopolymers. All together, we identified 71.6%
(13,486/18,840) of sites in the novel RNASEQR variant
calls as potential false positives. When comparing the
novel RNASEQR variants between GM12878 data and
PBMC data, we found 3,173 shared sites between two indi-
viduals. Of the 3,173 sites, 2,882 (90.8%) were among the
filtered sites, whereas only 1,266 (39.9%) were A>G and
T>C variants (potential RNA-editing sites). These results
suggest that systematic errors in the RNASEQR mapping
can occur in multiple individuals.
Although SNPiR called fewer SNPs and achieved higher
precision than did RNASEQR, its sensitivity was also higher
in coding regions. Of the 23,878 coding SNPs identified
from WGS, SNPiR identified 9,607 (40.2%) and RNASEQR
identified 5,571 (23.3%) (Figure 7B). Considering all
54,891 coding and UTR SNPs that were identified from
WGS, SNPiR was able to detect 21,608 (39.4%) and RNA-
SEQR detected 13,562 (24.7%). This demonstrates the
capability of our splice-aware mapping procedure to avoid
the incorrect mapping of entire reads. It also highlights the
importance of our filtering process, which specifically re-
moves false-positive variants.an Journal of Human Genetics 93, 641–651, October 3, 2013 647
Discussion
In this work, we have devised SNPiR, a computational
approach that allows the accurate identification of
genomic variants from transcriptome sequencing through
the combination of a splice-aware RNA-seq read-mapping
procedure and subsequent variant filtering that takes the
specifics of RNA-seq experiments into account. We applied
SNPiR to the RNA-seq data from two individuals whose ge-
nomes and exomes had been deeply sequenced. On both
data sets, SNPiR was able to detect genomic variants at
high precision by removing false-positive calls. The usage
of RNA-seq data allowed us to enrich for variants in func-
tionally important regions and to achieve high sensitivity
in variant calling in expressed exonic regions. This high
precision and sensitivity were also maintained for low-
coverage sequencing data.
Of paramount importance to us was to achieve the high-
est possible accuracy of SNP calling from RNA-seq experi-
ments. For that purpose, we adapted a read-mapping strat-
egy that allows us to reduce the number of falsely mapped
reads. Reads are simultaneously mapped to the reference
genome and to short pseudochromosomes created from se-
quences around all currently known splice junctions.
Although this restricts our mapping to known isoforms
and, unlike other RNA-seq mappers,15,24–26 lacks the abil-
ity to discover novel splice junctions, it avoids the incor-
rect placement of reads from highly similar locations.
RNA-seq mappers that initially map reads to the transcrip-
tome can be restricted by the incompleteness of the tran-
scriptome and force reads from unannotated regions to
be mapped into transcripts. Similarly, initial mapping to
the reference genome alone can force split reads to be map-
ped in a continuous fashion to a suboptimal location. Both
scenarios result in falsely mapped reads and thus false SNP
calls. SNPiR is able to avoid both cases by using genome
and transcriptome information simultaneously. Similarly
to SNPiR, the most recent version of TopHat (TopHat2)42
can take genome and transcriptome information simulta-
neously into account during mapping. We tested the per-
formance of TopHat2 as a replacement for our mapping
strategy by calling variants and applying all SNPiR filtering
steps to the complete set of GM12878 RNA-seq reads that
were mapped with TopHat2. We found that TopHat2 map-
pings allowed the identification of more total variants.
However, these were less precise and lacked the sensitivity
of SNPiR mappings in coding regions (Figure S8). More-
over, our simple mapping procedure, based on the BWA
as the mapper, is at least four times faster on the same
RNA-seq sequencing library.
Calling of genomic variants from RNA-seq data can have
manifold applications. It enables researchers to use their
readily available RNA-seq data to profile samples for
known variants or allows confirmation of variants that
were detected by genome sequencing (e.g., validation of
somatic mutations related to cancer). Furthermore, it per-
mits the detection of previously unknown variants that648 The American Journal of Human Genetics 93, 641–651, Octobermight carry important functional implications. For
instance, we observed that proportionally more novel var-
iants were found in the previously unstudied PBMC data
than in the GM12878 data (the novel/known ratio was
0.024 in PBMC data and 0.004 in GM12878 data), in
which nucleotide variation is well characterized through
the HapMap and 1000 Genomes projects.1,2 This confirms
our initial hypothesis that more novel RNA variants would
be found in previously unstudied data sets, promising a
substantial yield of novel variants from other data sets.
Although previous screens were able to uncover common
genomic variants, the power of our analysis lies in the
diverse origin of RNA-seq samples and individuals, em-
powering us to detect rare SNPs that were not observed
before51 at minimal additional cost. Many of the rare and
low-frequency variants are thought to be functionally
important and responsible for the heritability of complex
diseases.52 Given the relatively small overlap between the
regions targeted by RNA-seq and WES, our method might
also find its application in the discovery of variants associ-
ated with rare Mendelian diseases—especially in genomic
regions that are not captured by WES experiments. For
nonhuman species without large-scale genome
sequencing efforts such as the 1000 Genomes Project,
SNPiR has the potential to identify a lot more novel SNPs
in the RNA-seq data, which can be obtained at a lower
cost. For nonmodel species without available reference ge-
nomes, sequencing the RNA and calling RNA variants
might be a very efficient approach to identifying genetic
markers that allow genetic mapping of traits of interest.53
Further development of SNPiR will be needed for meeting
the challenges of accurate read mapping without a well-
assembled genome and a well-annotated transcriptome.
Finally, in tumor sequencing projects such as the Cancer
Genome Atlas (TCGA), often the genome and/or exome
and RNA are both sequenced. Calling variants in the tumor
samples with the genome and/or exome sequencing data is
even more challenging because of the complexity of the
tumors (such as the heterogeneous nature). The ability to
independently call variants in the RNA-seq data will serve
as an efficient means to validate a large number of somatic
mutations identified in the genome and/or exome data.
SNPiR shows high performance in variant calling and
opens the door to many applications by using RNA-seq
data. At the same time, its abilities are limited by the nature
of RNA-seq experiments. SNPiR is predicated on the dis-
covery of functionally relevant variants, which, in most
cases, requires the expression of the transcript harboring
the variant. This becomes evident through the relatively
small overlap between variants detected from WES and
RNA-seq. WES experiments are specifically designed to
target predefined regions of interest (predominantly the
protein-coding portion of the genome). As such, WES
can identify variation in these regions with high sensi-
tivity, whereas comprehensive coverage and variant detec-
tion in the same portions of the genome are not guaran-
teed by RNA-seq because of the potential lack of3, 2013
expression. Furthermore, tissue-specific gene expression
might hamper the discovery of genomic variants given
that the collection of tissues related to the phenotype
can be challenging and easily accessible tissues might not
express the genes with disease-related variants. Further-
more, nonsense variants might be missed by our method
as a result of nonsense-mediated decay. Nevertheless,
SNPiR allows the detection of variants even for lowly ex-
pressed genes (Figure 4). In some cases, this translates to
as few as two to three reads per genomic locus. For obtain-
ing higher confidence in the called variants, pooling of
multiple data sets from the same individual (e.g., RNA-
seq from different tissues) can help to increase the coverage
and to facilitate variant discovery in regions of interest that
would otherwise lack sufficient coverage. This study, as
well as our previous work,13 demonstrates that variant call-
ing from RNA-seq experiments can tremendously profit
from an increased number of reads as the coverage of
genomic regions increases. Nevertheless, our subsampling
of the RNA-seq data shows that small sample sizes also
allow reliable calling of variants and enrich for variants
in exonic regions (Figure 5) as a result of the overall higher
coverage of exons compared to UTRs, introns, and inter-
genic positions. On the other hand, the simultaneous us-
age of multiple data sets from different individuals can
help to avoid systematic errors in variant detection.
Although the filtering steps in SNPiR effectively remove
false positives from single data sets, systematic errors
might still persist across data sets. In general, most com-
mon variants have already been discovered by previous
sequencing projects and appear in dbSNP. Therefore,
genuine novel variation is most likely to be restricted to
few individuals. Variants present in many samples are
likely to be either RNA-editing events, as exemplified by
the shared novel variants between the two data sets in
the SNPiR analysis, or systematic errors, as shown in the
case of the shared variants in the RNASEQR mappings.
These recurring variants can be identified via cross-com-
parison of variant calls between different RNA-seq data
sets. We also anticipate that the rapidly growing atlas of
known RNA-editing sites will permit the removal of such
positions with increasing efficiency in the future. Alterna-
tively, if highly confident variant calls are essential, all
A>G variants may be removed.
In addition to failing to call genomic variants in genes
that are not expressed, SNPiR might encounter difficulty
in calling variants in expressed genes as a result of mono-
allelic expression (in which only one parental allele is ex-
pressed). When only the reference allele is expressed, the
SNP will remain undetected. When only the nonreference
allele is expressed, the SNP will be miscalled as a homozy-
gous rather than a heterozygous variant. However, previ-
ous work suggests that only 5%–10% of human genes are
subject to monoallelic expression,54 which is also reflected
in our results. In the total set of genes with FPKM > 5, we
detected >80% of all coding variants (Figure 4), suggesting
that less than 20% of all coding variation will escape detec-The Americtion and only part of it might be attributable to monoal-
lelic expression.
Despite the limitations of calling genomic variants from
RNA-seq data, our work demonstrates the feasibility of SNP
calling from RNA-seq data with high precision and sensi-
tivity. The framework described in this work will not
replace WGS or WES approaches but rather presents a
viable alternative to these two approaches in cases where
neither of them is available nor cost effective. Our
approach might complement whole-exome variant calling
and be used to validate SNPs that were discovered by either
WGS or WES. Therefore, it presents a powerful tool that
will empower the exploration of SNPs at the genomic level
from RNA-seq data alone.
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